Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.08 USD
Change Today +0.13 / 4.41%
Volume 127.7K
As of 5:20 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter G. Traber M.D.

Chief Executive Officer, President, Chief Medical Officer and Director, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 160 board members in 3 different organizations across 3 different industries.

See Board Relationships
58$2,252,052
As of Fiscal Year 2014

Background*

Dr. Peter G. Traber, M.D. has been the Chief Executive Officer and President of Galectin Therapeutics, Inc. (alternate name, Pro-Pharmaceuticals Inc.) since March 17, 2011 and serves as its Chief Medical Officer. Dr. Traber serves as the President Emeritus of Baylor College of Medicine. Dr. Traber served as an Acting Chief Medical Officer of Galectin Therapeutics, Inc. since June 15, 2010. Dr. Traber served as the President and Chief Executive Officer, Professor of ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

Director
2004-N/A
Former Director
2009-Present
Chief Executive Officer, President, Chief Medical Officer and Director
2015-Present
Director

Education*

BS
University of Michigan
MD
Wayne State University School of Medicine Detroit

Other Affiliations*

Annual Compensation*

Salary$485,000
Bonus$213,400
Total Annual Compensation$698,400

Stock Options*

All Other Compensation$41,502
Exercisable Options1,023,796
Exercisable Options Value$522,988
Unexercisable Options446,873
Unexercisable Options Value$60,813
Total Value of Options$583,800
Total Number of Options1,470,669

Total Compensation*

Total Annual Cash Compensation$739,902
Total Short Term Compensation$698,400
Other Long Term Compensation$41,502
Total Calculated Compensation$2,252,052
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $3.08 USD +0.13

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.